AlzChem Group AG (ACT.BE)

Compare

99.40

-8.60

(-7.96%)

At close: March 18 at 7:50:02 PM GMT+1

Investors Shouldn't Overlook AlzChem Group's (ETR:ACT) Impressive Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Simply Wall St. 16 hours ago

ALZCF
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80

AlzChem Group AG ( ETR:ACT ) will increase its dividend from last year's comparable payment on the 13th of May to...

Simply Wall St. 14 days ago

ALZCF
AlzChem Group's (ETR:ACT) investors will be pleased with their splendid 282% return over the last five years

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Simply Wall St. last month

ALZCF
If EPS Growth Is Important To You, AlzChem Group (ETR:ACT) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St. last month

ALZCF
Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)?

While AlzChem Group AG ( ETR:ACT ) might not have the largest market cap around , it saw a significant share price rise...

Simply Wall St. 3 months ago

ALZCF
AlzChem Group AG (ETR:ACT) has caught the attention of institutional investors who hold a sizeable 45% stake

Key Insights Given the large stake in the stock by institutions, AlzChem Group's stock price might be vulnerable to...

Simply Wall St. 3 months ago

ALZCF
AlzChem Group Third Quarter 2024 Earnings: EPS: €1.22 (vs €0.85 in 3Q 2023)

AlzChem Group ( ETR:ACT ) Third Quarter 2024 Results Key Financial Results Revenue: €132.7m (up 7.0% from 3Q 2023). Net...

Simply Wall St. 4 months ago

ALZCF
Is AlzChem Group AG's (ETR:ACT) Latest Stock Performance A Reflection Of Its Financial Health?

AlzChem Group's (ETR:ACT) stock is up by a considerable 26% over the past month. Given that the market rewards strong...

Simply Wall St. 4 months ago

ALZCF
The Return Trends At AlzChem Group (ETR:ACT) Look Promising

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

Simply Wall St. 5 months ago

ALZCF
Estimating The Fair Value Of AlzChem Group AG (ETR:ACT)

Key Insights Using the 2 Stage Free Cash Flow to Equity, AlzChem Group fair value estimate is €38.37 With €40.80 share...

Simply Wall St. 5 months ago

ALZCF
AlzChem Group (ETR:ACT) shareholders have earned a 25% CAGR over the last five years

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Simply Wall St. 6 months ago

ALZCF
Statutory Profit Doesn't Reflect How Good AlzChem Group's (ETR:ACT) Earnings Are

AlzChem Group AG ( ETR:ACT ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests...

Simply Wall St. 7 months ago

ALZCF
AlzChem Group Second Quarter 2024 Earnings: EPS: €0.71 (vs €0.70 in 2Q 2023)

AlzChem Group ( ETR:ACT ) Second Quarter 2024 Results Key Financial Results Revenue: €139.9m (up 5.2% from 2Q 2023...

Simply Wall St. 7 months ago

ALZCF
What Does AlzChem Group AG's (ETR:ACT) Share Price Indicate?

AlzChem Group AG ( ETR:ACT ), is not the largest company out there, but it saw a significant share price rise of 45% in...

Simply Wall St. 8 months ago

ALZCF
It's Unlikely That AlzChem Group AG's (ETR:ACT) CEO Will See A Huge Pay Rise This Year

Key Insights AlzChem Group to hold its Annual General Meeting on 7th of May Salary of €315.0k is part of CEO Andreas...

Simply Wall St. 10 months ago

ALZCF
AlzChem Group's (ETR:ACT) Returns Have Hit A Wall

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

Simply Wall St. 10 months ago

ALZCF
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 67% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, AlzChem Group fair value estimate is €72.16 AlzChem Group is...

Simply Wall St. 10 months ago

ALZCF
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group AG ( ETR:ACT ) will increase its dividend from last year's comparable payment on the 10th of May to...

Simply Wall St. 11 months ago

ALZCF
Investors in AlzChem Group (ETR:ACT) have seen decent returns of 82% over the past year

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...

Simply Wall St. 11 months ago

ALZCF

Performance Overview

Return	ACT.BE	DAX P (^GDAXI)
YTD	+75.62%	+17.44%
1-Year	+218.18%	+30.38%
3-Year	+369.11%	+62.22%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AlzChem Group AG (ACT.BE)

Investors Shouldn't Overlook AlzChem Group's (ETR:ACT) Impressive Returns On Capital

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80

AlzChem Group's (ETR:ACT) investors will be pleased with their splendid 282% return over the last five years

If EPS Growth Is Important To You, AlzChem Group (ETR:ACT) Presents An Opportunity

Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)?

AlzChem Group AG (ETR:ACT) has caught the attention of institutional investors who hold a sizeable 45% stake

AlzChem Group Third Quarter 2024 Earnings: EPS: €1.22 (vs €0.85 in 3Q 2023)

Is AlzChem Group AG's (ETR:ACT) Latest Stock Performance A Reflection Of Its Financial Health?

The Return Trends At AlzChem Group (ETR:ACT) Look Promising

Estimating The Fair Value Of AlzChem Group AG (ETR:ACT)

AlzChem Group (ETR:ACT) shareholders have earned a 25% CAGR over the last five years

Statutory Profit Doesn't Reflect How Good AlzChem Group's (ETR:ACT) Earnings Are

AlzChem Group Second Quarter 2024 Earnings: EPS: €0.71 (vs €0.70 in 2Q 2023)

What Does AlzChem Group AG's (ETR:ACT) Share Price Indicate?

It's Unlikely That AlzChem Group AG's (ETR:ACT) CEO Will See A Huge Pay Rise This Year

AlzChem Group's (ETR:ACT) Returns Have Hit A Wall

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 67% Above Its Share Price

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Investors in AlzChem Group (ETR:ACT) have seen decent returns of 82% over the past year

Performance Overview